The Wuhan Institute of Virology has developed a new nasal Covid-19 vaccine intended to offer extensive protection against existing and future coronavirus variants. Tested on mice, it demonstrated effectiveness against multiple Sars-CoV-2 strains. Published in ACS Nano, the research highlights the necessity for vaccines providing broad-spectrum protection amid continuous and potential future coronavirus threats.
from Times of India https://ift.tt/S9Z0eTi
https://ift.tt/2wY7S64
0 Comments